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Summary
What is already known on this topic?
Previous work demonstrated the potential long-term impact of clinical and
community interventions to prevent chronic disease. However, that work
considered only hypothetical interventions that may not accurately reflect
the feasibility of implementation in a real-world setting.
What is added by this report?
We examined the potential 10- and 25-year impact of clinical and com-
munity interventions to prevent chronic disease as they were implemen-
ted under the Community Transformation Grant program.
What are the implications for public health practice?
Results support public health practitioners in strategic planning for chron-
ic disease prevention.
Abstract
Introduction
Public health focuses on a range of evidence-based approaches for
addressing chronic conditions, from individual-level clinical inter-
ventions to broader changes in policies and environments that pro-
tect people’s health and make healthy living easier. This study ex-
amined the potential long-term impact of clinical and community
interventions as they were implemented by Community Trans-
formation Grant (CTG) program awardees.
Methods
We used the Prevention Impacts Simulation Model, a system dy-
namics model of cardiovascular disease prevention, to simulate the
potential 10-year and 25-year impact of clinical and community
interventions implemented by 32 communities receiving a CTG
program award, assuming that program interventions were sus-
tained during these periods.
Results
Sustained clinical interventions implemented by CTG awardees
could potentially avert more than 36,000 premature deaths and
$3.2 billion in discounted direct medical costs (2017 US dollars)
over 10 years and 109,000 premature deaths and $8.1 billion in
discounted medical costs over 25 years. Sustained community in-
terventions could avert more than 24,000 premature deaths and
$3.4 billion in discounted direct medical costs over 10 years and
88,000 premature deaths  and $9.1 billion in  discounted direct
medical costs over 25 years. CTG clinical activities had cost-ef-
fectiveness of $302,000 per death averted at the 10-year mark and
$188,000 per death averted at the 25-year mark. Community inter-
ventions had cost-effectiveness of $169,000 and $57,000 per death
averted at the 10- and 25-year marks, respectively.
Conclusion
Clinical interventions have the potential to avert more premature
deaths than community interventions. However, community inter-
ventions, if sustained over the long term, have better cost-effect-
iveness.
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Introduction
Public and private sector stakeholders have worked together for
decades to prevent chronic disease, improve quality of life, and re-
duce medical  costs  and death associated with chronic disease.
Evidence-based approaches  for  addressing chronic  conditions
range from individual-level clinical interventions addressing bet-
ter  identification  and  control  of  chronic  diseases  to  broader
changes in policies and environments around diet, physical activ-
ity, and smoking that make healthy living easier in a community.
Public health now focuses on all these areas but recognizes that
different interventions may have different potential impacts (1).
Assessing the potential impact of interventions is challenging, be-
cause interventions take time to affect health and economic out-
comes. As a result, only a small part of the impact of these inter-
ventions can be quantified in the first few years through observing
program reach and initial impact on behaviors. Simulation model-
ing is a useful tool to extend the time horizon for assessing the po-
tential long-term impact of clinical and community interventions.
Previous comparisons of clinical and community interventions
generally considered policy change scenarios that may not have
accurately reflected the real-world applications of these interven-
tions (2). In this study, we simulated the potential 10- and 25-year
impacts of 2 types of interventions as they were implemented as
part of the Community Transformation Grant (CTG) program, a
large multicommunity public health program funded by the Cen-
ters for Disease Control and Prevention (CDC) from 2011 through
2014.
Methods
The CTG program is a large-scale example of a program that sup-
ported the implementation of both clinical and community ap-
proaches to address chronic disease (3). CTG awardees were re-
quired to address at least one of the following focus areas: 1) in-
crease options for tobacco-free living (eg, smoke-free policies for
workplaces or multiunit housing), 2) promote and improve access
to opportunities for active living and healthy eating (eg, working
with partners to build bike paths and increase the availability of
fruits and vegetables at corner stores), 3) increase use of clinical
and community preventive services (eg, community health worker
initiatives), and/or 4) expand access to healthy and safe physical
environments (eg, Safe Streets initiatives) (4). After a competitive
application process, CDC allocated $103 million to 61 state and
local government agencies, tribes and territories, and nonprofit or-
ganizations in 36 states, covering 130 million people (3,5).
We used the CTG program as an example of a chronic disease pre-
vention program to estimate the long-term potential health and
economic outcomes of clinical and community interventions if
they were sustained at the same level over time. We used informa-
tion on the classifications of interventions that were conducted as
part of the CTG program and their reach as inputs to the Preven-
tion Impacts Simulation Model (PRISM) to estimate the potential
long-term impact of clinical and community interventions. In the
CTG program, reach was operationalized as the estimated number
of people in the target population who had increased access to (eg,
those living within 1 mile of a park), are protected by (eg, a work-
place smoke-free policy), or are otherwise affected by (eg, pa-
tients covered by a community health worker program) an inter-
vention (6).
PRISM is a computer simulation model containing mathematical
equations that describe how risk factors interact to produce chron-
ic disease and poor health outcomes and the impacts of various
community  and  clinical  interventions.  PRISM calculates  out-
comes annually and cumulatively from 1990 through 2040 (7–10).
PRISM was validated in several ways during its development and
has been used to estimate the long-term impact  of  other  com-
munity health programs, such as the Communities Putting Preven-
tion to Work program (11) and public health prevention activities
of the Los Angeles County Public Health Department (12).
PRISM includes a wide range of chronic disease–related interme-
diate outcomes that can be influenced by clinical and community
intervention strategies.  These strategies are represented in the
model as “levers,” which reflect changes in the numbers of people
reached by the strategy. Lever movement provides an estimate of
the intent-to-treat population and not the population that changed
their health behaviors as a result of lever movement. PRISM simu-
lates  the  impact  of  lever  movement  on cardiovascular  disease
(CVD) risk behaviors, like smoking and physical activity in the
reached population, by applying published estimates of the effect
of increased access on health behavior. For example, building a
park  would  increase  the  lever  for  access  to  physical  activity
spaces; PRISM then simulates the impact on physical activity for
the portion of the reached population that used the park and in-
creased their physical activity. These impacts on risk factors, in
turn, reduce the prevalence of cardiovascular disease, pulmonary
disease, lung cancer, and resulting deaths and costs. PRISM in-
cludes levers that address tobacco use; nutrition; physical activity;
clinical care for preventing or mitigating hypertension, diabetes,
and high cholesterol; and aspirin use. Most PRISM levers are rep-
resented by an index ranging from 0 (no implementation of the
strategy) to 1 (optimal implementation of the strategy across the
entire  population).  Because  PRISM  levers  represent  broad
strategies to improve access, each PRISM lever can be moved by
one or more evidence-based interventions. For example, the lever
“Increasing access to physical activity spaces” can be moved by
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each of 10 interventions that are expected to produce a positive
health outcome, including bike shares (13–17), safe-streets initiat-
ives (18,19),  parks (19-21),  and joint-use agreements (22–24).
Each evidence-based intervention was assigned to an intensity cat-
egory (minimal, low, medium, and high) that represented its abil-
ity to move the lever for those reached by the intervention. The in-
tensity category was assigned primarily on the basis of the impact
of the intervention estimated in the literature. A list of all evid-
ence-based interventions that can move each lever and details on
the process of generating the list and assigning intensity categor-
ies are available in an online supplement (https://forio.com/app/
cdc/prism/#/resources).
PRISM simulation outcomes reflect the impact of changes in lever
settings compared with baseline trends (ie, no change from the
status quo).  Baseline PRISM levers were set  to reflect  a com-
munity’s public health environment pre-intervention (ie, before
the CTG program began, in 2011). For example, when analyzing
the impact of increasing access to physical activity spaces, we did
not simply assume that a community started from a baseline ac-
cess level of zero, but instead we used publicly available informa-
tion about each community’s policies and environment to estim-
ate the baseline level for each lever. Baseline lever settings were
determined by reviewing data and literature on the existing envir-
onment for physical activity, nutrition, tobacco, and clinical ser-
vices policies, such as city, county, and state information from the
literature, and secondary data sources, such as the US Census Bur-
eau and the National Health and Nutrition Examination Survey.
Translating CTG activities into PRISM inputs
Building on previous work (11), we used the RE-AIM (reach, ef-
fectiveness, adoption, implementation, maintenance) framework to
translate CTG activities into PRISM lever inputs for simulation
modeling (25–27). The evaluation focused on reach and effective-
ness. To assess reach, we used awardee-submitted estimates of the
number  of  people  reached  by  their  activities.  CDC  provided
awardees with written guidance on estimating reach, including
metrics, definitions, and potential data sources. Awardees were
also encouraged to obtain technical assistance from CDC project
officers when estimating intervention reach. Reach was operation-
alized as the estimated number of people in the target population
who had increased access to (eg, those living within 1 mile of a
park), are protected by (eg, a workplace smoke-free policy), or af-
fected by (eg, patients covered by a community health worker pro-
gram) an intervention (6). Determining reach included 1) docu-
menting the setting where the intervention was implemented dur-
ing the funding period, 2) using census data or setting-specific
data (eg, school enrollment) to identify the population count for
the setting where the intervention was implemented, and 3) ag-
gregating data. If interventions were implemented in settings or
populations that potentially overlapped, the overlap was estimated
and accounted for in the aggregation process. Submitted reach es-
timates were reviewed and validated by trained CDC program of-
ficers, subject matter experts, and contractors by using census,
school enrollment, and other local data sources.
Because reach was an intent-to-treat metric, not all people reached
by the intervention will use the intervention or change their beha-
vior as a result of access. The model incorporates effect-size es-
timates  for  the  proportion  reached  whose  use  and  behavior
changes (ie, the estimated proportion of people in the target popu-
lation who have increased access to or are protected by an inter-
vention). Because PRISM is a population model representing the
entire community, the denominator for proportional reach was the
entire adult population, child population, or the total population of
the targeted community as indicated by the US Census Bureau.
To assess effectiveness, we used information on the interventions
completed by each awardee as reported in the annual reports sub-
mitted to CDC. A team of coders reviewed each awardee’s pro-
gress reports and determined which evidence-based interventions
(https://forio.com/app/cdc/prism/#/resources) were conducted as
part of each awardee activity. Each evidence-based intervention
was assigned a categorical intensity that was used to determine the
PRISM lever  movement.  For 20% of the awardee activities,  a
second coder performed a secondary review for quality control,
and the 2 coders reconciled differences.
We computed the lever movement for each activity by taking the
intensity of the interventions conducted as part of that awardee’s
activity and multiplying by proportional reach. We then computed
the total  lever movement for each awardee by aggregating the
lever movements for all of that awardee’s activities that affected
each lever.
We estimated the impact of a subset of CTG activities that met our
criteria for being evidence-based on premature deaths averted and
medical costs saved after 10 and 25 years. The goal of the CTG
program was to implement clinical and community interventions
that could be sustained into the future with minimal further input,
so we assumed that all interventions would be sustained at a con-
stant level and that maintenance costs would be incurred for at
least 10 and 25 years. We also examined the projected program
implementation costs of awardee activities (including program
maintenance costs) and the projected impact on risk factor man-
agement costs to calculate the total cost and cost-effectiveness of
the CTG program. We constructed cost-effectiveness ratios as the
sum of implementation costs and net medical costs (ie, risk factor
management costs minus medical cost savings) divided by the in-
cremental health gains of the program (ie, premature deaths pre-
vented).  We estimated the impact of each awardee’s activities
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overall and separately for clinical and community levers. We ex-
amined  the  median  and  range  of  the  estimated  impact  across
awardees and the aggregate for all CTG awardees. Medical costs
were inflated to 2017 dollars by using the medical cost compon-
ent of the Consumer Price Index (28). Future cost savings were
discounted by 3% per year (29).
We conducted a probabilistic sensitivity analysis in which model
parameters were varied across a distribution assumed on the basis
of the literature (29) to estimate the lower and upper bounds of a
95% confidence interval for premature deaths averted, risk factor
management costs, medical costs saved, and cost per premature
death averted.
Results
Of the 61 CTG program awardees, 29 worked to build capacity for
public health interventions and did not implement any interven-
tions. The remaining 32 awardees implemented interventions that
could be translated into PRISM levers and were included in this
analysis.  These  awardees  covered  a  population  of  87  million
people. They implemented clinical interventions reaching 19 mil-
lion people, community tobacco interventions reaching 20 million
people, community nutrition interventions reaching 37 million
people, and community physical activity interventions reaching 26
million people.
CTG awardees worked on interventions that affected 21 different
PRISM levers (Table 1). Thirty awardees worked on interventions
targeting community PRISM levers (including nutrition, physical
activity, and tobacco) and 12 awardees worked on interventions
targeting clinical PRISM levers. Physical activity access was the
lever  addressed  by  the  largest  number  of  CTG awardees  (20
awardees) and was increased an average of 20 percentage points
across all awardees (ie, a 20 percentage-point increase in the num-
ber of people with access to places where they can engage in phys-
ical activity). Smoke-free multiunit housing was implemented by
18 awardees, with an average movement of 10 percentage points
(ie,  a  10 percentage-point  decrease in  multiunit  housing com-
plexes that permit smoking). Other levers moved in our analysis
were fruit and vegetable access (12 awardees, average movement
= 12 percentage points), physical activity promotion (15 awardees,
average movement = 7 percentage points), physical activity re-
quirements in schools (13 awardees, average movement = 11 per-
centage points), and workplace smoke-free policy (12 awardees,
average movement = 23 percentage points). The most frequently
implemented clinical interventions were related to improving qual-
ity care for people with diabetes (8 awardees, average movement =
12 percentage points), hypertension (7 awardees, average move-
ment = 8 percentage points), and high cholesterol (11 awardees,
average movement = 7 percentage points).
Results from PRISM simulations indicate that the projected 10-
year impact (from 2015 through 2024) of clinical levers moved by
CTG awardee activities would be more than 36,000 premature
deaths averted, $3.2 billion in discounted medical cost savings,
and $14.2 billion in risk factor management costs incurred (Table
2). The projected 10-year impact of community levers moved by
CTG awardee activities would be nearly 25,000 premature deaths
averted, $3.4 billion in discounted medical cost savings, and $3.0
billion in risk factor management costs incurred. The 10-year cost-
effectiveness of CTG clinical activities was $302,000 per prema-
ture death prevented. The estimated cost-effectiveness of CTG
community activities was $169,000 per premature death preven-
ted.
The projected 25-year impact (from 2015 through 2039) of clinic-
al levers moved by CTG awardee activities would be more than
109,000 premature deaths averted, $8.1 billion in discounted med-
ical  cost  savings,  and $28.4 billion in risk factor management
costs incurred (Table 2). The projected 25-year impact of com-
munity levers moved by CTG awardee activities would be more
than 88,000 premature deaths averted, $9.1 billion in discounted
medical cost savings, and $6.5 billion in risk factor management
costs incurred. The 25-year effectiveness of CTG clinical activit-
ies was $188,000 per premature death averted, and the 25-year ef-
fectiveness of CTG community activities was $57,000 per prema-
ture death averted.
Discussion
This analysis provides estimates of the effects of large-scale clin-
ical and community interventions as they were implemented dur-
ing the CTG program, complementing previous work estimating
the impact of hypothetical interventions (2). Results show that
CTG clinical activities were projected to avert more premature
deaths after 10 years and 25 years than CTG community interven-
tions, but that the gap between the intervention categories shrank
from the 10-year mark to the 25-year mark. However, CTG com-
munity interventions were projected to save more medical costs
after 10 years and 25 years than CTG clinical interventions; this
gap increased from the 10-year mark to the 25-year mark. Com-
munity interventions in the CTG program had much higher projec-
ted program implementation costs than clinical interventions, but
led to a much smaller increase in risk factor management costs at
the 10-year and 25-year marks. No standard benchmark exists to
assess  the  cost-effectiveness  in  relation  to  premature  deaths.
However, Neumann and colleagues recommended using $100,000
or $150,000 as acceptable amounts to pay per quality-adjusted life
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year (QALY) gained (30). A cost-effectiveness threshold for pre-
mature deaths prevented would be expected to be greater than that
for QALYs gained because, on average, preventing a premature
death is expected to have a higher value than 1 QALY. Based on
this cost-effectiveness threshold, sustained community interven-
tions would likely be considered cost-effective, especially when
considered over a period of 10 years or longer.
A previous study using similar methods evaluated another CDC-
funded  program,  Communities  Putting  Prevention  to  Work
(CPPW), and projected that the program would prevent 14,000
premature deaths in 51 communities during a 10-year period (11).
The larger number of premature deaths prevented by the CTG pro-
gram versus CPPW is likely attributable to the CTG program’s use
of clinical interventions, our additional analytic efforts to code
evidence-based interventions into PRISM, and the use of existing
infrastructure  by  high-capacity  awardees  to  implement  com-
munity health interventions.
Our analysis is subject to several limitations. First, all simulation
models are approximations to reality and are limited by the evid-
ence of effect sizes that is available. Second, we derived model in-
puts from awardee progress reports, which may overstate accom-
plishments. Third, although PRISM is a broad cardiovascular dis-
ease model, it accounts for most, but not all, strategies implemen-
ted  in  the  CTG program (eg,  it  does  not  account  for  outdoor
smoke-free air regulations). Fourth, the analysis assumes that all
activities would be sustained for 10 years and 25 years, which is
the most optimistic scenario possible. In reality, interventions of-
ten lose strength once they are no longer actively promoted. This
assumption may be more reasonable for interventions that change
policies or the community environment, but may be less realistic
for interventions that require regular ongoing support. Fifth, trans-
lating programmatic information into any simulation model  is
challenging, and quantifying community policy and environment-
al changes introduces aspects of subjectivity. The process used in
this analysis was refined from CPPW to reduce subjectivity by fo-
cusing on evidence-based interventions from the literature, all of
which were assigned to a given category of impact. This approach
is consistent with approaches used by others to estimate the “dose”
for community health interventions (25–27). Finally, this analysis
focused on the aggregate impact of the CTG program and did not
address variability in reach and potential health and economic out-
comes for specific awardees or target populations.
Study findings suggest that clinical and community interventions,
like those implemented in the CTG program, may be expected to
have substantial benefits. Clinical interventions have the potential
to prevent more premature deaths than community-based interven-
tions in both the intermediate (10 years) and long term (25 years).
However, sustaining community-based interventions over the long
term may save more in medical costs and have greater cost-effect-
iveness than investing in only clinical interventions.
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Tables
Table 1. Summary of PRISM Levers Moved as a Result of the Community Transformation Grant Program, Number of Communities that Moved Each Lever, and Aver-
age Movement of Leversa
PRISM Lever Description of Lever
No. of
Communities
Moving the Lever
Average Lever
Movement,
Percentage Pointsb
Community lever
Fruit and vegetable access The percentage of the population having convenient, affordable access to fresh
fruits and vegetables.
12 12
Fruit and vegetable promotion The extent of promotion for fruit and vegetable consumption through local
communication and food placement in the locations in which people typically
buy or consume food, as well as through mass media.
4 2
Physical activity access The percentage of adults with access to safe and affordable walking, biking,
social, and green space opportunities for physical activity in worksites and
community locations.
20 20
Physical activity promotion The extent of local communication, placement, and pricing of physical activity
options at worksites and in the community, as well as use of mass media and
social marketing.
15 7
Physical activity requirements in
childcare
The percentage of children aged 2 to 5 in daily childcare that is required to
meet recommended physical activity levels and not to exceed screen time
limits.
4 3
Physical activity requirements in
schools
The percentage of children aged 6 to 17 that is required to meet recommended
physical activity levels during school or in after-school programs.
13 11
Smoke-free multiunit housing The percentage of multiunit housing residents that live in housing that allows
smoking.
18 10
Smoke quit services The use of smoking quit services as affected by affordability, availability, and
outreach.
9 24
Smoking counter marketing Local communication about tobacco products in locations where people shop,
work, and live, as well as a mass media social marketing campaign.
5 4
Workplace smoke-free policies The percentage of indoor workplaces, including restaurants and bars, that allow
smoking.
12 23
Clinical lever
Use of quality CVD care after a CVD
event
The percentage of the post-CVD population receiving cardiovascular care
according to current clinical practice guidelines.
1 4
Use of quality diabetes care non-CVD The percentage of the non-CVD/post-CVD population with diagnosed diabetes
that is receiving diabetes care according to current clinical practice guidelines.
8 12
Use of quality diabetes care after a
CVD event
7 12
Use of quality high cholesterol care
non-CVD
The percentage of the non-CVD/post-CVD population with diagnosed high
cholesterol that is receiving cholesterol care according to current clinical
practice guidelines.
11 7
Use of quality high cholesterol care
after a CVD event
10 7
Use of quality hypertension care non-
CVD
The percentage of the non-CVD/post-CVD population with diagnosed
hypertension that is receiving hypertension care according to current clinical
7 8
Abbreviation: CVD, cardiovascular disease; PRISM, Prevention Impacts Simulation Model.
a PRISM is a computer simulation model containing mathematical equations that describe how risk factors interact to produce chronic disease and poor health out-
comes and the impacts of various community and clinical interventions (7–10). Clinical and community intervention strategies are represented in the model as
“levers,” which reflect changes in the numbers of people reached by the strategy.
b Movement is defined as an improvement from the baseline lever level (ie, percentage-point change from baseline). Movement reflects only changes in the frac-
tion of the targeted population that had increased access and does not reflect the percentage of people that changed behavior as a result of increases in the
levers.
(continued on next page)
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(continued)
Table 1. Summary of PRISM Levers Moved as a Result of the Community Transformation Grant Program, Number of Communities that Moved Each Lever, and Aver-
age Movement of Leversa
PRISM Lever Description of Lever
No. of
Communities
Moving the Lever
Average Lever
Movement,
Percentage Pointsb
Use of quality hypertension care
after a CVD event
practice guidelines. 7 8
Aspirin use compliance female, aged
<65
The percentage of prophylactic (daily or every other day) aspirin use among the
target population for whom such use is recommended by the US Preventive
Services Task Force.
1 1
Aspirin use compliance, female,
aged ≥65
1 1
Aspirin use compliance, male, aged
<65
1 1
Aspirin use compliance, male, aged
≥65
1 1
Abbreviation: CVD, cardiovascular disease; PRISM, Prevention Impacts Simulation Model.
a PRISM is a computer simulation model containing mathematical equations that describe how risk factors interact to produce chronic disease and poor health out-
comes and the impacts of various community and clinical interventions (7–10). Clinical and community intervention strategies are represented in the model as
“levers,” which reflect changes in the numbers of people reached by the strategy.
b Movement is defined as an improvement from the baseline lever level (ie, percentage-point change from baseline). Movement reflects only changes in the frac-
tion of the targeted population that had increased access and does not reflect the percentage of people that changed behavior as a result of increases in the
levers.
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Table 2. Projected 10-Year and 25-Year Cost-Effectiveness of Community Transformation Grant (CTG) Activities for Clinical and Community Leversa
Outcome Clinical Levers (N= 12) Community Levers (N= 30)
Projected 10-year cost-effectiveness
Premature deaths averted 36,530 (35,169–37,730) 24,486 (13,942–41,164)
CTG program implementation costs, $, billion 0.1 (0.1–0.1) 4.6 (3.9–5.3)
Discounted medical cost savings, $, billion 3.2 (3.0–3.4) 3.4 (2.2–5.5)
Risk factor management costs incurred, $, billion 14.2 (11.6–16.1) 3.0 (3.0–3.0)
Total costs,b $, billion 11.0 (8.3–13.2) 4.1 (2.8–4.8)
Cost per premature death averted,c $ 302,000 (220,000–374,000) 169,000 (68,000–342,000)
Projected 25-year cost-effectiveness
Premature deaths averted 109,130 (104,850–113,180) 88,374 (51,315–140,496)
CTG program implementation costs, $, billion 0.2 (0.2–0.2) 7.6 (6.4–8.8)
Discounted medical cost savings, $, billion 8.1 (7.6–8.5) 9.1 (5.7–14.3)
Risk factor management costs incurred, $, billion 28.4 (23.2-32.2) 6.5 (5.9–7.5)
Total costs,b $, billion 20.5 (15.0–24.8) 5.0 (2.0–6.7)
Cost per premature death averted,c $ 188,000 (132,000–236,000) 57,000 (14,000–130,000)
Abbreviation: CTG, Community Transformation Grant.
a All values are point estimate (lower bound–upper bound).
b Total costs = Program Implementation Costs – Medical Costs Averted + Risk Factor Management Costs Incurred.
c Cost per Death Averted = Total Costs/Deaths Averted.
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